A team from the Garvan Institute of Medical Research published a study in Immunity, finding that NK cells in patients with MKD and in disease models cannot properly release toxic granules. Instead, they release large amounts of interferon gamma, potentially contributing to excessive inflammation during infection. The study also explored baricitinib as an adjunct treatment in one severely affected child. The child experienced fewer inflammatory flares and began to heal from severe gastrointestinal inflammation, but findings from a single patient cannot establish its effectiveness in more patients.
Source:ScienceDaily · Read Original
Leave a Reply